-
effectivehealthcare.ahrq.gov/sites/default/files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - concept is used in multiple
contexts with differing definitions and sometimes is used to
indicate prescribing … I
fear the results of reviews such as this contribute to fear of
prescribing among primary care physicians … consideration in the context of the individual patient
before relying on this comparative harms data to make
prescribing … Resulting
drug-drug interactions and
pharmacokinetic changes must be taken
into consideration when prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - concept is used in multiple
contexts with differing definitions and sometimes is used to
indicate prescribing … I
fear the results of reviews such as this contribute to fear of
prescribing among primary care physicians … consideration in the context of the individual patient
before relying on this comparative harms data to make
prescribing … Resulting
drug-drug interactions and
pharmacokinetic changes must be taken
into consideration when prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - abdominal pain.38 Other adverse events associated with azithromycin that could dissuade a physician
from prescribing … KALYDECO (ivacaftor) tablets prescribing
information. [internet]. … Zithromax (azithromycin tablets) and (azithromycin
for oral suspension) prescribing information. … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
September 21, 2022 - Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
September 20, 2022 - Results, Function Results, QOL and Satisfaction with Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
January 01, 2007 - A
randomized, controlled trial of a clinical pharmacist
intervention to improve inappropriate prescribing … or problems)
55.0 5.6
Physician consultation (contact with the patient’s
primary care or other prescribing … Therapy tools and/or education for physicians
(provision of patient-specific reports, physician
prescribing
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-including-both-children-and-adult-subgroup-comparisons-with-type-1-diabetes-what-is-the-comparitive-differences-in-hba1c-levels-when-comparing-various-treatment-options-including-multiple-daily-injections-insulin
July 19, 2009 - The variations in clinical care - prescribing an insulin pump for a blind person who has type 2 diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Pricing, reimbursement, and prescribing barriers have been the priority for the manufacturers of
lorcaserin … The
recommended prescribing by the manufacturer includes an initial low-titration dosage and a
mid-titration … Drug Enforcement Administration as a Schedule IV drug; it
became available for prescribing in June … IV drug (i.e., with a low potential for abuse and low risk of dependence); it became
available for prescribing … Prescribing information for Belviq (lorcaserin
hydrochloride) tablets. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-d-surveillance-report-1.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study design
Duration Setting
Country Eligibility criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due To Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - appropriate to list
anti-sclerostin monoclonal antibody class-specific harms
in Table 3 when the final prescribing … Prescribing
Information, (06/2018).
Cummings SR, Ferrari S, Eastell R et al. … I suggest that the
committee carefully review the FDA-approved Prescribing
Information for each product … Prescribing
Information, (06/2018).
2Miller PD, Bolognese MA, Lew iecki EM et al. … Prescribing
Information, (06/2018).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - appropriate to list
anti-sclerostin monoclonal antibody class-specific harms
in Table 3 when the final prescribing … Prescribing
Information, (06/2018).
Cummings SR, Ferrari S, Eastell R et al. … I suggest that the
committee carefully review the FDA-approved Prescribing
Information for each product … Prescribing
Information, (06/2018).
2Miller PD, Bolognese MA, Lew iecki EM et al. … Prescribing
Information, (06/2018).
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol
April 26, 2013 - treatment, less than 1 in 10 receives medication as part of his or her treatment, which leads to a prescribing … Very low prescribing rates for these medications indicate that primary care providers are rarely using … Although primary care providers are proficient at prescribing a wide variety of medications, they generally … of subject recruitment), interventions (e.g., dose and frequency of administration; type of provider prescribing … of enrolled populations; co-occurring disorders of enrolled populations; setting; type of provider prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
January 27, 2012 - treatment, less than 1 in 10
receives medication as part of his or her treatment, which leads to a prescribing … Very low prescribing rates for these
medications indicate that primary care providers are rarely using … Although primary care providers are proficient at
prescribing a wide variety of medications, they generally … subject recruitment),
interventions (e.g., dose and frequency of administration; type of provider
prescribing … of enrolled
populations; co-occurring disorders of enrolled populations; setting; type of
provider prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - Clinical Bottom Line (Continued)
ALDH2 = aldehyde dehydrogenase 2
c The prescribing information sheet … Clinicians are advised to refer to the prescribing
information sheet for additional information on adverse
-
effectivehealthcare.ahrq.gov/products/migraine-treatments/protocol
January 08, 2020 - What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute episodic
-
effectivehealthcare.ahrq.gov/products/opioid-use-disorder/research-protocol
February 29, 2016 - increase from 2001). 4 These trends have occurred in conjunction with markedly increased rates of opioid prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
February 24, 2016 - increase from 2001).4 These trends have occurred in conjunction
with markedly increased rates of opioid prescribing
-
effectivehealthcare.ahrq.gov/products/medicare-medication-use/research
April 23, 2014 - Data Points #19: Medication Use in Medicare
Research Report April 23, 2014 Web Version [NLM Site] Download Main Document PDF 797.2 KB
People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us .
This report is from AHRQ's…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number: 0313
Document Completion Date: 12-12-11
1
Results of Topic Selection Process & Next Steps
Outcomes of serious mental illness will go forward for refinement as a systematic review. The scope of
this topic, including populations, interventions, comparators, and…